Civic Intelligence

Education Network to Advance Cancer

EIN 75-3170106 • 501(c)3 • Bethesda, MD

Profile

Enacct's mission is to improve access to cancer clinical trials through education and collaboration with communities, health care providers, and researchers. Enacct's vision is to achieve the highest quality cancer care and research through clinical trials.

7625 Wisconsin Avenue 3rd FloorBethesda, MD 20814

www.enacct.org

Siviq Scores

Precomputed percentiles relative to similar nonprofits. These scores are descriptive rather than judgmental.

Liabilities / Assets

Score unavailable

No value available

Liabilities-to-assets requires both liabilities and assets on the latest valid filing.

Source year 2014

Liabilities / Revenue

62nd percentile

0.00x

Tied with the lowest-debt nonprofits in its peer group.

501(c)3 • <$500k nonprofits • Source year 2014

Net Margin

4th percentile

-631%

Higher net margin than 4% of similar nonprofits.

501(c)3 • <$500k nonprofits • Source year 2014

Top Officer Pay

81st percentile

$0

Higher top officer pay than 81% of similar nonprofits.

Top officer pay equals 0.0% of source-year revenue.

501(c)3 • <$500k nonprofits • Source year 2014

Asset Growth

10th percentile

-100%

Faster asset growth than 10% of similar nonprofits.

501(c)3 • <$500k nonprofits • Annualized from 2013 to 2014

Revenue Growth

5th percentile

-95%

Faster revenue growth than 5% of similar nonprofits.

501(c)3 • <$500k nonprofits • Annualized from 2013 to 2014

Assets

Down

$0

Down $118,509 (-100%) from 2013

Liabilities

Down

$0

Down $22,321 (-100%) from 2013

Net Assets

Down

$0

Down $96,188 (-100%) from 2013

Revenue

Down

$15,255

Down $318,767 (-95%) from 2013

Expenses

Down

$111,443

Down $312,668 (-74%) from 2013

Net Income

Down

-$96,188

Down $6,099 (-6.8%) from 2013

Trend Graphs

Balance Sheet Trend

Grouped bars show assets, liabilities, and net assets across loaded filings.

$600K$400K$200K$0Assets 2010: $589,293Liabilities 2010: $131,945Net Assets 2010: $457,3482010Assets 2011: $388,400Liabilities 2011: $29,633Net Assets 2011: $358,7672011Assets 2012: $250,947Liabilities 2012: $64,670Net Assets 2012: $186,2772012Assets 2013: $118,509Liabilities 2013: $22,321Net Assets 2013: $96,1882013Assets 2014: $0Liabilities 2014: $0Net Assets 2014: $02014

Highlighted filing

2014

Assets$0
Liabilities$0
Net Assets$0

Operations Trend

Revenue, expenses, and net income by year, with the latest filing highlighted.

$1.5M$1.0M$500K$0-$500KExpenses 2010: $1,127,1262010Expenses 2011: $941,8102011Expenses 2012: $613,3502012Revenue 2013: $334,022Expenses 2013: $424,111Net Income 2013: -$90,0892013Revenue 2014: $15,255Expenses 2014: $111,443Net Income 2014: -$96,1882014

Highlighted filing

2014

Revenue$15,255
Expenses$111,443
Net Income-$96,188

Filings

Latest Filing Detail
Jump To
Filing Snapshot
Filing Period
Jan 1, 2014 to Dec 31, 2014
Signed
Nov 15, 2015
Return Version
2014v5.0
Gross Receipts
$15,255
Mission and Program Overview

Mission

Enacct's mission is to improve access to cancer clinical trials through education and collaboration with communities, health care providers, and researchers. Enacct's vision is to achieve the highest quality cancer care and research through clinical trials.

Balance Sheet Detail
LineBeginningEndChange
Assets
Savings and Temporary Cash Investments$69,343--
Accounts Receivable$45,832--
Cash and Non-Interest-Bearing Accounts$2,034--
Total Assets$118,509$0▼ $118,509
Other Assets Total$1,300--
Liabilities
Accounts Payable and Accrued Expenses$22,321--
Total Liabilities$22,321$0▼ $22,321
Net Assets / Fund Balance
Unrestricted Net Assets$96,188--
Total Net Assets Fund Balance$96,188$0▼ $96,188
Total Liabilities and Net Assets / Fund Balance$118,509$0▼ $118,509
Compensation and Service Providers

Board Members and Trustees

NameTitle
Bonnie CrawfordBoard Member
Carrie JonesBoard Member
Gwen DarienBoard Member
Loretta IrvinBoard Member
Maria GonzalezBoard Member
Nila SalibaBoard Member
Robert Caine MdBoard Member
Revenue and Support

Revenue Composition

Contributions and Grants
$15,146
Program Service Revenue
$0
Investment Income
$1
Other Revenue
$108
All Other Contributions
$15,146
Change in Net Assets
$-96,188
Expenses and Functional Allocation

Major Expense Lines

Line ItemAmount
Other Expenses$75,533
Salaries, Compensation, and Employee Benefits$35,910
Grants and Similar Amounts Paid$0
Professional Fundraising Fees$0
Total Fundraising Expense$0

Functional Expense Allocation

Line ItemProgramManagementFundraisingTotal
Fees for Services Other$55,876--$55,876
Current Officers, Directors, Trustees, and Key Employees$21,310--$21,310
Other Salaries and Wages$10,464--$10,464
Other Expenses$5,770--$5,770
Fees for Services Legal-$5,218-$5,218
Fees for Services Accounting-$4,500-$4,500
Payroll Taxes$3,498--$3,498
Insurance-$2,039-$2,039
Information Technology$70$1,060-$1,130
Other Employee Benefits$638--$638
Travel-$470-$470
Office Expenses-$330-$330
Occupancy-$200-$200
Total Functional Expenses$97,626$13,817$0$111,443
Fundraising, Events, and Gaming
Fundraising activities
No
Gaming activities
No
Professional fundraiser used
No

Fundraising and Gaming Totals

Line ItemAmount
Professional Fundraising Fees$0
Political and Lobbying Activity
Political campaign activity
No
Lobbying activity
No
Subject to proxy tax
No
Governance and Compliance

Governance Checklist

Compiled or reviewed by an accountant
No
Annual disclosure for covered persons
Yes
Business relationship with family members
No
Business relationship with organization members
No
Material changes to governing documents
No
Compensation from other sources disclosed
No
CEO compensation reviewed
Yes
Other officer compensation reviewed
No
Conflict-of-interest policy
Yes
Audited financial statements prepared
No
Key decisions subject to board approval
No
Management duties delegated
No

Governance Explanations

Form 990, Page 6, Part VI, Line 11B

The 990 was reviewed by the executive director. All changes were incorporated.

Form 990, Page 6, Part VI, Line 12C

Ennact's policy is reviewed yearly by staff through the employee manual and yearly evaluations. The policy is signed yearly by all board members.

Form 990, Page 6, Part VI, Line 15A

There is a yearly review of comparable salaries from national non-profits and those in dc. Salary ranges are reviewed and approved by executive committee of board.

Form 990, Page 6, Part VI, Line 19

Upon request copies are made and sent out of irs form 990's and 1023's

Filing and Contact Details

Filer

Filer Name
Education Network to Advance Cancer
EIN
75-3170106
Phone
3018937603
Address
7625 WISCONSIN AVENUE 3RD FLOOR, BETHESDA, MD 20814

Signing Officer

Name
Margo Michaels
Title
Exec Director and Pres of Board
Phone
3018937603
Signed
2015-11-15
Discuss with paid preparer
Yes

Organization Details

Principal Officer
Margo Michaels
Formed
2004
Legal Domicile
Md
Voting Board Members
8
Independent Board Members
7
Employees
2

Preparer

Firm
Coates & Hutchinson Pc
Address
P O BOX 561, ODENTON, MD 21113
Preparer
Theresa Hutchinson
Phone
4107213946
Supplemental Narrative

Additional Explanations

FORM 990 - ORGANIZATION'S MISSION

Enacct's mission is to improve access to cancer clinical trials through education and collaboration with communities, health care providers, and researchers. Enacct's vision is to achieve the highest quality cancer care and research through clinical trials.

Form 990, Page 2, Part III, Line 4A

"developed a patient discussion guide for boston medical center. The guide is intended to assist navigators in discussing potential trial participation in the clinic setting. Bmc use of the guide is pending. "completed promotion and monitoring of cme-accredited online training developed in collaboration with the center for asian health. The course was designed for primary care providers serving asian patients to increase their knowledge of cancer clinical trials, encourage discussion with patients about trials, and refer patients to cancer care sites that offer trials. Programs "planned and completed the national cancer clinical trials collaborative learning network, a patient-centered quality improvement program to improve cancer clinical trial recruitment, accrual and retention. The learning network provided 19 research teams - from both community oncology practices and academic center - with tools and techniques to identify and capitalize on specific opportunities for improvement to expand accrual and increase efficiency. Utilizing lessons learned and feedback from the original pilot learning collaborative, enacct showed the feasibility of using the model for research teams to effectively evaluate and review their current procedures for gaps and leaks. "continued hosting a free, monthly policy webinar series which aimed to raise awareness and enhance understanding of significant policy issues impacting cancer clinical trial accrual. Through this series, enacct was able to continue its advocacy for system changes to facilitate all cancer patients being screened for available trials, all trial eligible patients being approached by the oncologist and all trial eligible patients interested in participation being successfully enrolled. A total of 12 webinars were completed, averaging nearly 300 registrants and each receiving very positive feedback. "implemented patient navigation in cancer clinical trials, a pilot demonstration program designed to promote patient self-advocacy, question- listing and communication about potential research participation in the clinical trial setting. With input from a national advisory committee, the pilot selected 2 performance sites, with each institution implementing the intervention and monitoring trial accrual over a six month period. Development "developed the 360 cancer trial accrual self-assessment tool. This tool is designed to help community cancer centers and networks evaluate and improve their own cancer clinical trials accrual using 7 critical dimensions. The 7 dimensions include: (1) mission, strategy and vision, (2) trial selection and initiation, (3) people and tools, (4) accrual processes and procedures, (5) finance and management, (6) community outreach, and (7) communication practices. This tool is designed as a guided analysis which can be completed online, ideally by the cancer research leadership team with data provided by the staff. It is designed to focus the attention of the leadership team on both qualitative and quantitative factors across the critical dimensions of an effective clinical trials process. The tool includes three elements: (1) excel based data collection tool allowing for easy compilation and evaluation of all data needed to complete the assessment, (2) a web-based assessment survey intended to be completed by the research leadership team, and (3) the quick 360 survey which consists of a subset of questions from the web-based assessment survey and is intended to be completed by accruing physicians and research staff not involved in completing the web-based assessment. This tool was tested among 19 research teams. 100% of the teams found the process of completing the self-assessment to be very or somewhat helpful, and 92% found the results to be very or somewhat helpful in strategically identifying areas for improvement in their processes. "competencies for clinical trial accrual professionals. Following extensive review of existing professional standards fo

Form 990, Part IX, Line 11G

Expert consultants 15,700 0 0 trainers 14,805 0 0 consultants 25,371 0 0

Raw XML Appendix344 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990/AccountantCompileOrReviewInd0false
IRS990/AccountsPayableAccrExpnssGrp/BOYAmt022321
IRS990/AccountsReceivableGrp/BOYAmt045832
IRS990/ActivitiesConductedPrtshpInd0false
IRS990/ActivityOrMissionDesc0ENACCT'S MISSION IS TO IMPROVE ACCESS TO CANCER CLINICAL TRIALS THROUGH EDUCATION AND COLLABORATION WITH COMMUNITIES, HEALTH CARE PROVIDERS, AND RESEARCHERS. ENACCT'S VISION IS TO ACHIEVE THE HIGHEST QUALITY CANCER CARE AND RESEARCH THROUGH CLINICAL TRIALS.
IRS990/AllOtherContributionsAmt015146
IRS990/AnnualDisclosureCoveredPrsnInd0true
IRS990/BooksInCareOfDetail/BusinessName/BusinessNameLine1Txt0ENACCT - THE ORGANIZATION
IRS990/BooksInCareOfDetail/PhoneNum03018937603
IRS990/BooksInCareOfDetail/USAddress/AddressLine1Txt07625 WISCONSIN AVENUE 3RD FLOOR
IRS990/BooksInCareOfDetail/USAddress/CityNm0BETHESDA
IRS990/BooksInCareOfDetail/USAddress/StateAbbreviationCd0MD
IRS990/BooksInCareOfDetail/USAddress/ZIPCd020814
IRS990/BusinessRlnWithFamMemInd0false
IRS990/BusinessRlnWithOfficerEntInd0false
IRS990/BusinessRlnWithOrgMemInd0false
IRS990/CashNonInterestBearingGrp/BOYAmt02034
IRS990/ChangeToOrgDocumentsInd0false
IRS990/CollectionsOfArtInd0false
IRS990/CompCurrentOfcrDirectorsGrp/ProgramServicesAmt021310
IRS990/CompCurrentOfcrDirectorsGrp/TotalAmt021310
IRS990/CompensationFromOtherSrcsInd0false
IRS990/CompensationProcessCEOInd0true
IRS990/CompensationProcessOtherInd0false
IRS990/ConflictOfInterestPolicyInd0true
IRS990/ConservationEasementsInd0false
IRS990/ConsolidatedAuditFinclStmtInd0false
IRS990/ContractTerminationInd0X
IRS990/CreditCounselingInd0false
IRS990/CYBenefitsPaidToMembersAmt00
IRS990/CYContributionsGrantsAmt015146
IRS990/CYGrantsAndSimilarPaidAmt00
IRS990/CYInvestmentIncomeAmt01
IRS990/CYOtherExpensesAmt075533
IRS990/CYOtherRevenueAmt0108
IRS990/CYProgramServiceRevenueAmt00
IRS990/CYRevenuesLessExpensesAmt0-96188
IRS990/CYSalariesCompEmpBnftPaidAmt035910
IRS990/CYTotalExpensesAmt0111443
IRS990/CYTotalFundraisingExpenseAmt00
IRS990/CYTotalProfFndrsngExpnsAmt00
IRS990/CYTotalRevenueAmt015255
IRS990/DecisionsSubjectToApprovaInd0false
IRS990/DeductibleArtContributionInd0false
IRS990/DeductibleNonCashContriInd0false
IRS990/DelegationOfMgmtDutiesInd0false
IRS990/Desc0COMMUNITY TRAINING "HOSTED A FREE, LIVE INTERACTIVE WEB-BASED COMMUNITY AMBASSADOR TRAINING PROGRAM FOR 20 RESEARCH TEAMS. THE COMMUNITY AMBASSADOR TRAINING PROGRAM TRAINS COMMUNITY LEADERS TO RAISE AWARENESS AND INCREASING UNDERSTANDING OF CLINICAL TRIALS IN THEIR COMMUNITY. THE INTERACTIVE CORE CONTENT IS DESIGNED TO BE LOCALLY FOCUSED AND CULTURALLY TAILORED, TRAINING AMBASSADORS TO LEAD INFORMATION PRESENTATIONS ABOUT THE IMPORTANCE OF CANCER RESEARCH, ENCOURAGING INQUIRY ABOUT TRIALS AND "SPREADING THE WORD. THIS PEER-TO-PEER APPROACH ALLOWS FOR AN OPEN AND HONEST DIALOGUE ABOUT CLINICAL RESEARCH. HEALTH CARE PROVIDER TRAINING "DEVELOPED A PATIENT DISCUSSION GUIDE FOR BOSTON MEDICAL CENTER. THE GUIDE IS INTENDED TO ASSIST NAVIGATORS IN DISCUSSING POTENTIAL TRIAL PARTICIPATION IN THE CLINIC SETTING. BMC USE OF THE GUIDE IS PENDING. "COMPLETED PROMOTION AND MONITORING OF CME-ACCREDITED ONLINE TRAINING DEVELOPED IN COLLABORATION WITH THE CENTER FOR ASIAN HEALTH. THE COURSE WAS DESIGNED FOR PRIMARY CARE PROVIDERS SERVING ASIAN PATIENTS TO INCREASE THEIR KNOWLEDGE OF CANCER CLINICAL TRIALS, ENCOURAGE DISCUSSION WITH PATIENTS ABOUT TRIALS, AND REFER PATIENTS TO CANCER CARE SITES THAT OFFER TRIALS. PROGRAMS "PLANNED AND COMPLETED THE NATIONAL CANCER CLINICAL TRIALS COLLABORATIVE LEARNING NETWORK, A PATIENT-CENTERED QUALITY IMPROVEMENT PROGRAM TO IMPROVE CANCER CLINICAL TRIAL RECRUITMENT, ACCRUAL AND RETENTION. THE LEARNING NETWORK PROVIDED 19 RESEARCH TEAMS - FROM BOTH COMMUNITY ONCOLOGY PRACTICES AND ACADEMIC CENTER - WITH TOOLS AND TECHNIQUES TO IDENTIFY AND CAPITALIZE ON SPECIFIC OPPORTUNITIES FOR IMPROVEMENT TO EXPAND ACCRUAL AND INCREASE EFFICIENCY. UTILIZING LESSONS LEARNED AND FEEDBACK FROM THE ORIGINAL PILOT LEARNING COLLABORATIVE, ENACCT SHOWED THE FEASIBILITY OF USING THE MODEL FOR RESEARCH TEAMS TO EFFECTIVELY EVALUATE AND REVIEW THEIR CURRENT PROCEDURES FOR GAPS AND LEAKS. "CONTINUED HOSTING A FREE, MONTHLY POLICY WEBINAR SERIES WHICH AIMED TO RAISE AWARENESS AND ENHANCE UNDERSTANDING OF SIGNIFICANT POLICY ISSUES IMPACTING CANCER CLINICAL TRIAL ACCRUAL. THROUGH THIS SERIES, ENACCT WAS ABLE TO CONTINUE ITS ADVOCACY FOR SYSTEM CHANGES TO FACILITATE ALL CANCER PATIENTS BEING SCREENED FOR AVAILABLE TRIALS, ALL TRIAL ELIGIBLE PATIENTS BEING APPROACHED BY THE ONCOLOGIST AND ALL TRIAL ELIGIBLE PATIENTS INTERESTED IN PARTICIPATION BEING SUCCESSFULLY ENROLLED. A TOTAL OF 12 WEBINARS WERE COMPLETED, AVERAGING NEARLY 300 REGISTRANTS AND EACH RECEIVING VERY POSITIVE FEEDBACK. "IMPLEMENTED PATIENT NAVIGATION IN CANCER CLINICAL TRIALS, A PILOT DEMONSTRATION PROGRAM DESIGNED TO PROMOTE PATIENT SELF-ADVOCACY, QUESTION- LISTING AND COMMUNICATION ABOUT POTENTIAL RESEARCH PARTICIPATION IN THE CLINICAL TRIAL SETTING. WITH INPUT FROM A NATIONAL ADVISORY COMMITTEE, THE PILOT SELECTED 2 PERFORMANCE SITES, WITH EACH INSTITUTION IMPLEMENTING THE INTERVENTION AND MONITORING TRIAL ACCRUAL OVER A SIX MONTH PERIOD. DEVELOPMENT "DEVELOPED THE 360 CANCER TRIAL ACCRUAL SELF-ASSESSMENT TOOL. THIS TOOL IS DESIGNED TO HELP COMMUNITY CANCER CENTERS AND NETWORKS EVALUATE AND IMPROVE THEIR OWN CANCER CLINICAL TRIALS ACCRUAL USING 7 CRITICAL DIMENSIONS. THE 7 DIMENSIONS INCLUDE: (1) MISSION, STRATEGY AND VISION, (2) TRIAL SELECTION AND INITIATION, (3) PEOPLE AND TOOLS, (4) ACCRUAL PROCESSES AND PROCEDURES, (5) FINANCE AND MANAGEMENT, (6) COMMUNITY OUTREACH, AND (7) COMMUNICATION PRACTICES. THIS TOOL IS DESIGNED AS A GUIDED ANALYSIS WHICH CAN BE COMPLETED ONLINE, IDEALLY BY THE CANCER RESEARCH LEADERSHIP TEAM WITH DATA PROVIDED BY THE STAFF. IT IS DESIGNED TO FOCUS THE ATTENTION OF THE LEADERSHIP TEAM ON BOTH QUALITATIVE AND QUANTITATIVE FACTORS ACROSS THE CRITICAL DIMENSIONS OF AN EFFECTIVE CLINICAL TRIALS PROCESS. THE TOOL INCLUDES THREE ELEMENTS: (1) EXCEL BASED DATA COLLECTION TOOL ALLOWING FOR EASY COMPILATION AND EVALUATION OF ALL DATA NEEDED TO COMPLETE THE ASSESSMENT, (2) A WEB-BASED ASSESSMENT SURVEY INTENDED TO BE COMPLETED BY THE RESEARCH LEADER
IRS990/DescribedInSection501c3Ind0true
IRS990/DisregardedEntityInd0false
IRS990/DocumentRetentionPolicyInd0true
IRS990/DonorAdvisedFundInd0false
IRS990/ElectionOfBoardMembersInd0false
IRS990/EmployeeCnt02
IRS990/EmploymentTaxReturnsFiledInd0true
IRS990/EngagedInExcessBenefitTransInd0false
IRS990/ExpenseAmt097626
IRS990/FamilyOrBusinessRlnInd0false
IRS990/FederalGrantAuditRequiredInd0false
IRS990/FeesForServicesAccountingGrp/ManagementAndGeneralAmt04500
IRS990/FeesForServicesAccountingGrp/TotalAmt04500
IRS990/FeesForServicesLegalGrp/ManagementAndGeneralAmt05218
IRS990/FeesForServicesLegalGrp/TotalAmt05218
IRS990/FeesForServicesOtherGrp/ProgramServicesAmt055876
IRS990/FeesForServicesOtherGrp/TotalAmt055876
IRS990/FinalReturnInd0X
IRS990/ForeignActivitiesInd0false
IRS990/ForeignFinancialAccountInd0false
IRS990/ForeignOfficeInd0false
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt04.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt14.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt24.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt34.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt44.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt54.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt64.00
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd0X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd1X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd2X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd3X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd4X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd5X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd6X
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt00
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt10
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt20
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt30
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt40
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt50
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt60
IRS990/Form990PartVIISectionAGrp/PersonNm0BONNIE CRAWFORD
IRS990/Form990PartVIISectionAGrp/PersonNm1NILA SALIBA
IRS990/Form990PartVIISectionAGrp/PersonNm2GWEN DARIEN
IRS990/Form990PartVIISectionAGrp/PersonNm3CARRIE JONES
IRS990/Form990PartVIISectionAGrp/PersonNm4ROBERT CAINE MD
IRS990/Form990PartVIISectionAGrp/PersonNm5LORETTA IRVIN
IRS990/Form990PartVIISectionAGrp/PersonNm6MARIA GONZALEZ
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt40
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt50
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt60
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt40
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt50
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt60
IRS990/Form990PartVIISectionAGrp/TitleTxt0BOARD MEMBER
IRS990/Form990PartVIISectionAGrp/TitleTxt1BOARD MEMBER
IRS990/Form990PartVIISectionAGrp/TitleTxt2BOARD MEMBER
IRS990/Form990PartVIISectionAGrp/TitleTxt3BOARD MEMBER
IRS990/Form990PartVIISectionAGrp/TitleTxt4BOARD MEMBER
IRS990/Form990PartVIISectionAGrp/TitleTxt5BOARD MEMBER
IRS990/Form990PartVIISectionAGrp/TitleTxt6BOARD MEMBER
IRS990/Form990ProvidedToGvrnBodyInd0false
IRS990/FormationYr02004
IRS990/FormerOfcrEmployeesListedInd0false
IRS990/FSAuditedInd0false
IRS990/FundraisingActivitiesInd0false
IRS990/GamingActivitiesInd0false
IRS990/GoverningBodyVotingMembersCnt08
IRS990/GrantsToIndividualsInd0false
IRS990/GrantsToOrganizationsInd0false
IRS990/GrantToRelatedPersonInd0false
IRS990/GrossReceiptsAmt015255
IRS990/GroupReturnForAffiliatesInd0false
IRS990/IncludeFIN48FootnoteInd0false
IRS990/IndependentAuditFinclStmtInd0false
IRS990/IndependentVotingMemberCnt07
IRS990/IndoorTanningServicesInd0false
IRS990/InfoInScheduleOPartIIIInd0X
IRS990/InfoInScheduleOPartIXInd0X
IRS990/InfoInScheduleOPartVIInd0X
IRS990/InformationTechnologyGrp/ManagementAndGeneralAmt01060
IRS990/InformationTechnologyGrp/ProgramServicesAmt070
IRS990/InformationTechnologyGrp/TotalAmt01130
IRS990/InsuranceGrp/ManagementAndGeneralAmt02039
IRS990/InsuranceGrp/TotalAmt02039
IRS990/InvestmentIncomeGrp/ExclusionAmt01
IRS990/InvestmentIncomeGrp/TotalRevenueColumnAmt01
IRS990/InvestmentInJointVentureInd0false
IRS990/IRPDocumentCnt09
IRS990/IRPDocumentW2GCnt00
IRS990/LegalDomicileStateCd0MD
IRS990/LoanOutstandingInd0false
IRS990/LobbyingActivitiesInd0false
IRS990/LocalChaptersInd0false
IRS990/MaterialDiversionOrMisuseInd0false
IRS990/MembersOrStockholdersInd0false
IRS990/MethodOfAccountingAccrualInd0X
IRS990/MinutesOfCommitteesInd0true
IRS990/MinutesOfGoverningBodyInd0true
IRS990/MissionDesc0ENACCT'S MISSION IS TO IMPROVE ACCESS TO CANCER CLINICAL TRIALS THROUGH EDUCATION AND COLLABORATION WITH COMMUNITIES, HEALTH CARE PROVIDERS, AND RESEARCHERS. ENACCT'S VISION IS TO ACHIEVE THE HIGHEST QUALITY CANCER CARE AND RESEARCH THROUGH CLINICAL TRIALS.
IRS990/MoreThan5000KToIndividualsInd0false
IRS990/MoreThan5000KToOrgInd0false
IRS990/NetAssetsOrFundBalancesBOYAmt096188
IRS990/NetAssetsOrFundBalancesEOYAmt00
IRS990/NoListedPersonsCompensatedInd0X
IRS990/NondeductibleContributionsInd0false
IRS990/OccupancyGrp/ManagementAndGeneralAmt0200
IRS990/OccupancyGrp/TotalAmt0200
IRS990/OfficeExpensesGrp/ManagementAndGeneralAmt0330
IRS990/OfficeExpensesGrp/TotalAmt0330
IRS990/OfficerMailingAddressInd0false
IRS990/OperateHospitalInd0false
IRS990/Organization501c3Ind0X
IRS990/OrganizationFollowsSFAS117Ind0X
IRS990/OtherAssetsTotalGrp/BOYAmt01300
IRS990/OtherEmployeeBenefitsGrp/ProgramServicesAmt0638
IRS990/OtherEmployeeBenefitsGrp/TotalAmt0638
IRS990/OtherExpensesGrp/Desc0MISCELLANEOUS
IRS990/OtherExpensesGrp/ProgramServicesAmt05770
IRS990/OtherExpensesGrp/TotalAmt05770
IRS990/OtherRevenueMiscGrp/Desc0REIMBURSED EXPENSES
IRS990/OtherRevenueMiscGrp/RelatedOrExemptFuncIncomeAmt0108
IRS990/OtherRevenueMiscGrp/TotalRevenueColumnAmt0108
IRS990/OtherRevenueTotalAmt0108
IRS990/OtherSalariesAndWagesGrp/ProgramServicesAmt010464
IRS990/OtherSalariesAndWagesGrp/TotalAmt010464
IRS990/PartialLiquidationInd0false
IRS990/PayrollTaxesGrp/ProgramServicesAmt03498
IRS990/PayrollTaxesGrp/TotalAmt03498
IRS990/PoliticalCampaignActyInd0false
IRS990/PrincipalOfficerNm0MARGO MICHAELS
IRS990/ProfessionalFundraisingInd0false
IRS990/ProhibitedTaxShelterTransInd0false
IRS990/PYContributionsGrantsAmt0270627
IRS990/PYExcessBenefitTransInd0false
IRS990/PYInvestmentIncomeAmt0113
IRS990/PYOtherExpensesAmt0235925
IRS990/PYOtherRevenueAmt03782
IRS990/PYProgramServiceRevenueAmt059500
IRS990/PYRevenuesLessExpensesAmt0-90089
IRS990/PYSalariesCompEmpBnftPaidAmt0188186
IRS990/PYTotalExpensesAmt0424111
IRS990/PYTotalRevenueAmt0334022
IRS990/ReconcilationRevenueExpnssAmt0-96188
IRS990/RegularMonitoringEnfrcInd0true
IRS990/RelatedEntityInd0false
IRS990/RelatedOrganizationCtrlEntInd0false
IRS990/ReportInvestmentsOtherSecInd0false
IRS990/ReportLandBuildingEquipmentInd0false
IRS990/ReportOtherAssetsInd0false
IRS990/ReportOtherLiabilitiesInd0false
IRS990/ReportProgramRelatedInvstInd0false
IRS990/SavingsAndTempCashInvstGrp/BOYAmt069343
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearAmt015146
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus1YearAmt0270627
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus2YearsAmt0317915
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus3YearsAmt0632409
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus4YearsAmt0951097
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/TotalAmt02187194
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearAmt01
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus1YearAmt0113
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus2YearsAmt0416
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus3YearsAmt0565
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus4YearsAmt01419
IRS990ScheduleA/GrossInvestmentIncome170Grp/TotalAmt02514
IRS990ScheduleA/GrossReceiptsRltdActivitiesAmt0434521
IRS990ScheduleA/PublicOrganization170Ind0X
IRS990ScheduleA/PublicSupportCY170Pct00.61730
IRS990ScheduleA/PublicSupportPY170Pct00.69830
IRS990ScheduleA/PublicSupportTotal170Amt01351708
IRS990ScheduleA/SubstantialContributorsTotAmt0835486
IRS990ScheduleA/ThirtyThrPctSuprtTestsCY170Ind0X
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearAmt015146
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus1YearAmt0270627
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus2YearsAmt0317915
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus3YearsAmt0632409
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus4YearsAmt0951097
IRS990ScheduleA/TotalCalendarYear170Grp/TotalAmt02187194
IRS990ScheduleA/TotalSupportAmt02189708
IRS990ScheduleB/ContributorInformationGrp/ContributorBusinessName/BusinessNameLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorNum0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine20RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/City0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/State0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/ZIPCode0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/TotalContributionsAmt0RESTRICTED
IRS990/ScheduleBRequiredInd0true
IRS990/ScheduleJRequiredInd0false
IRS990ScheduleN/AssetsDistributedInd0true
IRS990ScheduleN/BondsOutstandingInd0false
IRS990ScheduleN/DirectorOfSuccessorInd0false
IRS990ScheduleN/EmployeeOfSuccessorInd0false
IRS990ScheduleN/LiabilitiesPaidInd0true
IRS990ScheduleN/OwnerOfSuccessorInd0false
IRS990ScheduleN/ReceiveCompensationInd0false
IRS990ScheduleN/RequiredToNotifyAGInd0false
IRS990/ScheduleORequiredInd0true
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt0ENACCT'S MISSION IS TO IMPROVE ACCESS TO CANCER CLINICAL TRIALS THROUGH EDUCATION AND COLLABORATION WITH COMMUNITIES, HEALTH CARE PROVIDERS, AND RESEARCHERS. ENACCT'S VISION IS TO ACHIEVE THE HIGHEST QUALITY CANCER CARE AND RESEARCH THROUGH CLINICAL TRIALS.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt1"DEVELOPED A PATIENT DISCUSSION GUIDE FOR BOSTON MEDICAL CENTER. THE GUIDE IS INTENDED TO ASSIST NAVIGATORS IN DISCUSSING POTENTIAL TRIAL PARTICIPATION IN THE CLINIC SETTING. BMC USE OF THE GUIDE IS PENDING. "COMPLETED PROMOTION AND MONITORING OF CME-ACCREDITED ONLINE TRAINING DEVELOPED IN COLLABORATION WITH THE CENTER FOR ASIAN HEALTH. THE COURSE WAS DESIGNED FOR PRIMARY CARE PROVIDERS SERVING ASIAN PATIENTS TO INCREASE THEIR KNOWLEDGE OF CANCER CLINICAL TRIALS, ENCOURAGE DISCUSSION WITH PATIENTS ABOUT TRIALS, AND REFER PATIENTS TO CANCER CARE SITES THAT OFFER TRIALS. PROGRAMS "PLANNED AND COMPLETED THE NATIONAL CANCER CLINICAL TRIALS COLLABORATIVE LEARNING NETWORK, A PATIENT-CENTERED QUALITY IMPROVEMENT PROGRAM TO IMPROVE CANCER CLINICAL TRIAL RECRUITMENT, ACCRUAL AND RETENTION. THE LEARNING NETWORK PROVIDED 19 RESEARCH TEAMS - FROM BOTH COMMUNITY ONCOLOGY PRACTICES AND ACADEMIC CENTER - WITH TOOLS AND TECHNIQUES TO IDENTIFY AND CAPITALIZE ON SPECIFIC OPPORTUNITIES FOR IMPROVEMENT TO EXPAND ACCRUAL AND INCREASE EFFICIENCY. UTILIZING LESSONS LEARNED AND FEEDBACK FROM THE ORIGINAL PILOT LEARNING COLLABORATIVE, ENACCT SHOWED THE FEASIBILITY OF USING THE MODEL FOR RESEARCH TEAMS TO EFFECTIVELY EVALUATE AND REVIEW THEIR CURRENT PROCEDURES FOR GAPS AND LEAKS. "CONTINUED HOSTING A FREE, MONTHLY POLICY WEBINAR SERIES WHICH AIMED TO RAISE AWARENESS AND ENHANCE UNDERSTANDING OF SIGNIFICANT POLICY ISSUES IMPACTING CANCER CLINICAL TRIAL ACCRUAL. THROUGH THIS SERIES, ENACCT WAS ABLE TO CONTINUE ITS ADVOCACY FOR SYSTEM CHANGES TO FACILITATE ALL CANCER PATIENTS BEING SCREENED FOR AVAILABLE TRIALS, ALL TRIAL ELIGIBLE PATIENTS BEING APPROACHED BY THE ONCOLOGIST AND ALL TRIAL ELIGIBLE PATIENTS INTERESTED IN PARTICIPATION BEING SUCCESSFULLY ENROLLED. A TOTAL OF 12 WEBINARS WERE COMPLETED, AVERAGING NEARLY 300 REGISTRANTS AND EACH RECEIVING VERY POSITIVE FEEDBACK. "IMPLEMENTED PATIENT NAVIGATION IN CANCER CLINICAL TRIALS, A PILOT DEMONSTRATION PROGRAM DESIGNED TO PROMOTE PATIENT SELF-ADVOCACY, QUESTION- LISTING AND COMMUNICATION ABOUT POTENTIAL RESEARCH PARTICIPATION IN THE CLINICAL TRIAL SETTING. WITH INPUT FROM A NATIONAL ADVISORY COMMITTEE, THE PILOT SELECTED 2 PERFORMANCE SITES, WITH EACH INSTITUTION IMPLEMENTING THE INTERVENTION AND MONITORING TRIAL ACCRUAL OVER A SIX MONTH PERIOD. DEVELOPMENT "DEVELOPED THE 360 CANCER TRIAL ACCRUAL SELF-ASSESSMENT TOOL. THIS TOOL IS DESIGNED TO HELP COMMUNITY CANCER CENTERS AND NETWORKS EVALUATE AND IMPROVE THEIR OWN CANCER CLINICAL TRIALS ACCRUAL USING 7 CRITICAL DIMENSIONS. THE 7 DIMENSIONS INCLUDE: (1) MISSION, STRATEGY AND VISION, (2) TRIAL SELECTION AND INITIATION, (3) PEOPLE AND TOOLS, (4) ACCRUAL PROCESSES AND PROCEDURES, (5) FINANCE AND MANAGEMENT, (6) COMMUNITY OUTREACH, AND (7) COMMUNICATION PRACTICES. THIS TOOL IS DESIGNED AS A GUIDED ANALYSIS WHICH CAN BE COMPLETED ONLINE, IDEALLY BY THE CANCER RESEARCH LEADERSHIP TEAM WITH DATA PROVIDED BY THE STAFF. IT IS DESIGNED TO FOCUS THE ATTENTION OF THE LEADERSHIP TEAM ON BOTH QUALITATIVE AND QUANTITATIVE FACTORS ACROSS THE CRITICAL DIMENSIONS OF AN EFFECTIVE CLINICAL TRIALS PROCESS. THE TOOL INCLUDES THREE ELEMENTS: (1) EXCEL BASED DATA COLLECTION TOOL ALLOWING FOR EASY COMPILATION AND EVALUATION OF ALL DATA NEEDED TO COMPLETE THE ASSESSMENT, (2) A WEB-BASED ASSESSMENT SURVEY INTENDED TO BE COMPLETED BY THE RESEARCH LEADERSHIP TEAM, AND (3) THE QUICK 360 SURVEY WHICH CONSISTS OF A SUBSET OF QUESTIONS FROM THE WEB-BASED ASSESSMENT SURVEY AND IS INTENDED TO BE COMPLETED BY ACCRUING PHYSICIANS AND RESEARCH STAFF NOT INVOLVED IN COMPLETING THE WEB-BASED ASSESSMENT. THIS TOOL WAS TESTED AMONG 19 RESEARCH TEAMS. 100% OF THE TEAMS FOUND THE PROCESS OF COMPLETING THE SELF-ASSESSMENT TO BE VERY OR SOMEWHAT HELPFUL, AND 92% FOUND THE RESULTS TO BE VERY OR SOMEWHAT HELPFUL IN STRATEGICALLY IDENTIFYING AREAS FOR IMPROVEMENT IN THEIR PROCESSES. "COMPETENCIES FOR CLINICAL TRIAL ACCRUAL PROFESSIONALS. FOLLOWING EXTENSIVE REVIEW OF EXISTING PROFESSIONAL STANDARDS FO
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt2THE 990 WAS REVIEWED BY THE EXECUTIVE DIRECTOR. ALL CHANGES WERE INCORPORATED.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt3ENNACT'S POLICY IS REVIEWED YEARLY BY STAFF THROUGH THE EMPLOYEE MANUAL AND YEARLY EVALUATIONS. THE POLICY IS SIGNED YEARLY BY ALL BOARD MEMBERS.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt4THERE IS A YEARLY REVIEW OF COMPARABLE SALARIES FROM NATIONAL NON-PROFITS AND THOSE IN DC. SALARY RANGES ARE REVIEWED AND APPROVED BY EXECUTIVE COMMITTEE OF BOARD.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt5UPON REQUEST COPIES ARE MADE AND SENT OUT OF IRS FORM 990'S AND 1023'S
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt6EXPERT CONSULTANTS 15,700 0 0 TRAINERS 14,805 0 0 CONSULTANTS 25,371 0 0
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc0FORM 990 - ORGANIZATION'S MISSION
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc1FORM 990, PAGE 2, PART III, LINE 4A
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc2FORM 990, PAGE 6, PART VI, LINE 11B
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc3FORM 990, PAGE 6, PART VI, LINE 12C
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc4FORM 990, PAGE 6, PART VI, LINE 15A
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc5FORM 990, PAGE 6, PART VI, LINE 19
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc6FORM 990, PART IX, LINE 11G
IRS990/SchoolOperatingInd0false
IRS990/SignificantChangeInd0false
IRS990/SignificantNewProgramSrvcInd0false
IRS990/SubjectToProxyTaxInd0false
IRS990/TaxablePartyNotificationInd0false
IRS990/TaxExemptBondsInd0false
IRS990/TempOrPermanentEndowmentsInd0false
IRS990/TerminateOperationsInd0true
IRS990/TotalAssetsBOYAmt0118509
IRS990/TotalAssetsEOYAmt00
IRS990/TotalAssetsGrp/BOYAmt0118509
IRS990/TotalAssetsGrp/EOYAmt00
IRS990/TotalCompGreaterThan150KInd0false
IRS990/TotalContributionsAmt015146
IRS990/TotalEmployeeCnt02
IRS990/TotalFunctionalExpensesGrp/FundraisingAmt00
IRS990/TotalFunctionalExpensesGrp/ManagementAndGeneralAmt013817
IRS990/TotalFunctionalExpensesGrp/ProgramServicesAmt097626
IRS990/TotalFunctionalExpensesGrp/TotalAmt0111443
IRS990/TotalGrossUBIAmt00
IRS990/TotalLiabilitiesBOYAmt022321
IRS990/TotalLiabilitiesEOYAmt00
IRS990/TotalLiabilitiesGrp/BOYAmt022321
IRS990/TotalLiabilitiesGrp/EOYAmt00
IRS990/TotalNetAssetsFundBalanceGrp/BOYAmt096188
IRS990/TotalNetAssetsFundBalanceGrp/EOYAmt00
IRS990/TotalProgramServiceExpensesAmt097626
IRS990/TotalRevenueGrp/ExclusionAmt01
IRS990/TotalRevenueGrp/RelatedOrExemptFuncIncomeAmt0108
IRS990/TotalRevenueGrp/TotalRevenueColumnAmt015255
IRS990/TotLiabNetAssetsFundBalanceGrp/BOYAmt0118509
IRS990/TotLiabNetAssetsFundBalanceGrp/EOYAmt00
IRS990/TravelGrp/ManagementAndGeneralAmt0470
IRS990/TravelGrp/TotalAmt0470
IRS990/TrnsfrExmptNonChrtblRltdOrgInd0false
IRS990/TypeOfOrganizationCorpInd0X
IRS990/UnrelatedBusIncmOverLimitInd0false
IRS990/UnrestrictedNetAssetsGrp/BOYAmt096188
IRS990/UponRequestInd0X
IRS990/USAddress/AddressLine1Txt07625 WISCONSIN AVENUE 3RD FLOOR
IRS990/USAddress/CityNm0BETHESDA
IRS990/USAddress/StateAbbreviationCd0MD
IRS990/USAddress/ZIPCd020814
IRS990/VotingMembersGoverningBodyCnt08
IRS990/VotingMembersIndependentCnt07
IRS990/WebsiteAddressTxt0WWW.ENACCT.ORG
IRS990/WhistleblowerPolicyInd0true
ReturnHeader/BuildTS02016-04-25 22:37:26Z
ReturnHeader/BusinessOfficerGrp/DiscussWithPaidPreparerInd0true
ReturnHeader/BusinessOfficerGrp/PersonNm0MARGO MICHAELS
ReturnHeader/BusinessOfficerGrp/PersonTitleTxt0EXEC DIR AND PRES OF BOARD
ReturnHeader/BusinessOfficerGrp/PhoneNum03018937603
ReturnHeader/BusinessOfficerGrp/SignatureDt02015-11-15
ReturnHeader/Filer/BusinessName/BusinessNameLine1Txt0EDUCATION NETWORK TO ADVANCE CANCER
ReturnHeader/Filer/BusinessName/BusinessNameLine2Txt0CLINICAL TRIALS
ReturnHeader/Filer/BusinessNameControlTxt0EDUC
ReturnHeader/Filer/EIN0753170106
ReturnHeader/Filer/PhoneNum03018937603
ReturnHeader/Filer/USAddress/AddressLine1Txt07625 WISCONSIN AVENUE 3RD FLOOR
ReturnHeader/Filer/USAddress/CityNm0BETHESDA
ReturnHeader/Filer/USAddress/StateAbbreviationCd0MD
ReturnHeader/Filer/USAddress/ZIPCd020814
ReturnHeader/PreparerFirmGrp/PreparerFirmEIN0521639708
ReturnHeader/PreparerFirmGrp/PreparerFirmName/BusinessNameLine1Txt0COATES & HUTCHINSON PC
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/AddressLine1Txt0P O BOX 561
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/CityNm0ODENTON
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/StateAbbreviationCd0MD
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/ZIPCd021113
ReturnHeader/PreparerPersonGrp/PhoneNum04107213946
ReturnHeader/PreparerPersonGrp/PreparationDt02015-11-16
ReturnHeader/PreparerPersonGrp/PreparerPersonNm0THERESA HUTCHINSON
ReturnHeader/ReturnTs02015-11-16T14:25:35-06:00
ReturnHeader/ReturnTypeCd0990
ReturnHeader/TaxPeriodBeginDt02014-01-01
ReturnHeader/TaxPeriodEndDt02014-12-31
ReturnHeader/TaxYr02014

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Peer Organizations

Similar nonprofits based on the same Siviq industry and scale cohort. 501(c)3 • <$500k nonprofits